Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct
Frederick Sinha, Anna Federlein, Annika Biesold, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

State-of-the-art-review Mechanisms of action of SGLT2 inhibitors and clinical implications
Volker Vallon
American Journal of Hypertension (2024) Vol. 37, Iss. 11, pp. 841-852
Closed Access | Times Cited: 13
Dapagliflozin treatment in patients with chronic kidney disease associated with autosomal dominant polycystic kidney disease
Masatoshi Yoshimoto, Akinari Sekine, Tatsuya Suwabe, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 4
Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series
Junji Nishida, Mayuko Yamakawa, Shoko Miura, et al.
CEN Case Reports (2025)
Open Access
Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter‐2 inhibition in experimental rats
Xinglin Wu, Sarah Macklin, Yanling Zhang, et al.
Journal of Diabetes Investigation (2025)
Open Access
Effect of SGLT2 inhibition on salt-induced hypertension in female Dahl SS rats
Olha Kravtsova, Vladislav Levchenko, Christine A. Klemens, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Dapagliflozin administration for 1 year promoted kidney enlargement in patient with ADPKD
Shinya Nakatani, Fumiyuki Morioka, Hideki Uedono, et al.
CEN Case Reports (2023) Vol. 13, Iss. 4, pp. 284-289
Open Access | Times Cited: 8
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice
Blythe D. Shepard, Jennifer Chau, Ryan Kurtz, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 4, pp. C1272-C1290
Closed Access | Times Cited: 2
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial
Liv Vernstrøm, Søren Gullaksen, Steffen S. Sørensen, et al.
Diabetologia (2024) Vol. 67, Iss. 10, pp. 2175-2187
Open Access | Times Cited: 1
Correlation of HbA1c levels with CT-based body composition biomarkers in diabetes mellitus and metabolic syndrome
Joshua Warner, Glen M. Blake, John W. Garrett, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Correlation of HbA1c levels with CT-based body composition biomarkers in diabetes mellitus and metabolic syndrome
Joshua Warner, Glen M. Blake, John W. Garrett, et al.
Research Square (Research Square) (2024)
Open Access
Impact of Impaired Kidney Function on Arrhythmia-Promoting Cardiac Ion Channel Regulation
Frederick Sinha, Frank Schweda, Lars S. Maier, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14198-14198
Open Access
Page 1

Scroll to top